Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells

HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be used as an anticancer therapy in addition to the designated applications. In the present study, we explored the possible synergistic pro-apop...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 365; no. 2; pp. 386 - 392
Main Authors Gan, Yehua, Wang, Jian, Coselli, Joseph, Wang, Xing Li
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 11.01.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be used as an anticancer therapy in addition to the designated applications. In the present study, we explored the possible synergistic pro-apoptotic effects and the underlying mechanisms when the two classes of inhibitors were combined. Exposure of HeLa cells to the combined treatment of mevastatin (an inhibitor of HMG-CoA reductase) and trichostatin A (TSA) (an inhibitor of HDACs) synergistically induced apoptosis. Mevastatin treatment transcriptionally and translationally up-regulated RhoA expression in the cells by negative feedback mechanism. While TSA enhanced mevastatin-induced RhoA up-regulation, more importantly, it also accelerated mevastatin-mediated depletion of membrane-bound (geranylgeranylated) RhoA. Moreover, TSA treatment down-regulated protein geranylgeranyl transferase-I (GGTase-I) β subunit expression, which is one of the key enzymes for protein geranylgeranylation. Taken together, TSA down-regulated GGTase-I β expression, hence enhanced the statin-induced depletion of geranylgeranylated RhoA, which could be an important mechanism for the synergistic induction of the apoptosis.
AbstractList HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be used as an anticancer therapy in addition to the designated applications. In the present study, we explored the possible synergistic pro-apoptotic effects and the underlying mechanisms when the two classes of inhibitors were combined. Exposure of HeLa cells to the combined treatment of mevastatin (an inhibitor of HMG-CoA reductase) and trichostatin A (TSA) (an inhibitor of HDACs) synergistically induced apoptosis. Mevastatin treatment transcriptionally and translationally up-regulated RhoA expression in the cells by negative feedback mechanism. While TSA enhanced mevastatin-induced RhoA up-regulation, more importantly, it also accelerated mevastatin-mediated depletion of membrane-bound (geranylgeranylated) RhoA. Moreover, TSA treatment down-regulated protein geranylgeranyl transferase-I (GGTase-I) β subunit expression, which is one of the key enzymes for protein geranylgeranylation. Taken together, TSA down-regulated GGTase-I β expression, hence enhanced the statin-induced depletion of geranylgeranylated RhoA, which could be an important mechanism for the synergistic induction of the apoptosis.
HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be used as an anticancer therapy in addition to the designated applications. In the present study, we explored the possible synergistic pro-apoptotic effects and the underlying mechanisms when the two classes of inhibitors were combined. Exposure of HeLa cells to the combined treatment of mevastatin (an inhibitor of HMG-CoA reductase) and trichostatin A (TSA) (an inhibitor of HDACs) synergistically induced apoptosis. Mevastatin treatment transcriptionally and translationally up-regulated RhoA expression in the cells by negative feedback mechanism. While TSA enhanced mevastatin-induced RhoA up-regulation, more importantly, it also accelerated mevastatin-mediated depletion of membrane-bound (geranylgeranylated) RhoA. Moreover, TSA treatment down-regulated protein geranylgeranyl transferase-I (GGTase-I) beta subunit expression, which is one of the key enzymes for protein geranylgeranylation. Taken together, TSA down-regulated GGTase-I beta expression, hence enhanced the statin-induced depletion of geranylgeranylated RhoA, which could be an important mechanism for the synergistic induction of the apoptosis.
HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be used as an anti-cancer therapy in addition to the designated applications. In the present study, we explored the possible synergistic pro-apoptotic effects and the underlying mechanisms when the two classes of inhibitors were combined. Exposure of HeLa cells to the combined treatment of mevastatin (an inhibitor of HMG CoA reductase) and trichostatin A (TSA) (an inhibitor of HDACs) synergistically induced apoptosis. Mevastatin treatment transcriptionally and translationally up-regulated RhoA expression in the cells by negative feedback mechanism. While TSA enhanced mevastatin-induced RhoA up-regulation, more importantly, it also accelerated mevastatin-mediated depletion of membrane-bound (geranylgeranylated) RhoA. Moreover, TSA treatment down-regulated protein geranylgeranyl transferase-I (GGTase-I) β subunit expression, which is one of the key enzymes for protein geranylgeranylation. Taken together, TSA down-regulated GGTase-I β expression, hence enhanced the statin-induced depletion of geranylgeranylated RhoA, which could be an important mechanism for the synergistic induction of the apoptosis.
Author Gan, Yehua
Wang, Jian
Wang, Xing Li
Coselli, Joseph
AuthorAffiliation b Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Texas Heart Institute at St Luke’s Episcopal Hospital, Baylor College of Medicine, Houston, Texas 77030
a Laboratory of Molecular Biology, Peking University School and Hospital of Stomatology, Beijing 100081, China
AuthorAffiliation_xml – name: b Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Texas Heart Institute at St Luke’s Episcopal Hospital, Baylor College of Medicine, Houston, Texas 77030
– name: a Laboratory of Molecular Biology, Peking University School and Hospital of Stomatology, Beijing 100081, China
Author_xml – sequence: 1
  givenname: Yehua
  surname: Gan
  fullname: Gan, Yehua
  email: kqyehuagan@bjmu.edu.cn
  organization: Laboratory of Molecular Biology and Center for TMJ Disorders, Peking University School and Hospital of Stomatology, 22 Zhongguancun Nandajie, Beijing 100081, PR China
– sequence: 2
  givenname: Jian
  surname: Wang
  fullname: Wang, Jian
  organization: Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Texas Heart Institute at St. Luke’s Episcopal Hospital, MS NAB 2010, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
– sequence: 3
  givenname: Joseph
  surname: Coselli
  fullname: Coselli, Joseph
  organization: Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Texas Heart Institute at St. Luke’s Episcopal Hospital, MS NAB 2010, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
– sequence: 4
  givenname: Xing Li
  surname: Wang
  fullname: Wang, Xing Li
  email: xlwang@bcm.tmc.edu
  organization: Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Texas Heart Institute at St. Luke’s Episcopal Hospital, MS NAB 2010, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17996726$$D View this record in MEDLINE/PubMed
BookMark eNp9kcFq3DAQhkVJaTZJX6CHolNvdkeyLVtQCmFps4UtPbSF3IQkj7NavNJW8gb27SuzS5tcctJhvvk0M_8VufDBIyHvGJQMmPi4LY2JtuQAbclYCcBfkQUDCQVnUF-QBQCIgkt2f0muUtoCMFYL-YZcslZK0XKxIPHn0WN8cGlyljrfH-zkgqdhoHof9lNILlFzpKvvd8Uy3NKIM6ETZnbjjJtCpNr3dJMFeTjao7Y4HcdMpCeI83SFa00tjmO6Ia8HPSZ8e36vye-vX34tV8X6x9235e26sHVXT4XR0sraNNJ2Q1-LRnRNN1Ri6KTVYLkQUoDpGiE5VgPTDcPKVKwS1kBru05W1-Tzybs_mB32Fv0U9aj20e10PKqgnXpe8W6jHsKj4qxhHEQWfDgLYvhzwDSpnUvzCtpjOCTFoe6g5ZBBfgJtDClFHP59wkDNUamtmqNSc1SKMZWjyk3vn473v-WcTQY-nQDMR3p0GFWyDr3F3kW0k-qDe8n_Fw6eqUI
CitedBy_id crossref_primary_10_1016_j_ejmech_2017_05_016
crossref_primary_10_1016_j_bbrc_2008_07_012
crossref_primary_10_1080_13543776_2016_1216977
crossref_primary_10_1124_jpet_117_242081
crossref_primary_10_1016_j_procbio_2013_06_002
crossref_primary_10_1021_jm400179b
crossref_primary_10_1002_jcb_24491
crossref_primary_10_1016_j_oraloncology_2009_05_563
crossref_primary_10_1016_j_gendis_2023_06_030
crossref_primary_10_1371_journal_pone_0029144
crossref_primary_10_1016_j_bbalip_2013_06_005
crossref_primary_10_1093_jmcb_mjaa066
crossref_primary_10_3390_ijms18051010
crossref_primary_10_3389_fonc_2022_790537
crossref_primary_10_1016_j_ejmech_2020_112844
Cites_doi 10.1016/S0304-3835(01)00412-8
10.1016/S0021-9150(01)00613-X
10.1023/B:BREA.0000018423.47497.c6
10.1038/nrc1612
10.1093/carcin/bgi036
10.1016/S0168-8278(01)00257-4
10.1016/S0898-6568(02)00124-9
10.1002/(SICI)1521-4184(199910)332:10<353::AID-ARDP353>3.0.CO;2-X
10.1016/j.bbrc.2005.11.151
10.1097/00001622-200111000-00010
10.1158/0008-5472.CAN-04-2440
10.1158/0008-5472.CAN-03-2631
10.1042/BST0330891
10.1074/jbc.M412960200
10.1677/erc.1.01012
10.1161/01.RES.0000037983.07158.B1
10.1016/S0006-291X(03)00323-1
10.1016/S0021-9258(18)41945-X
10.1161/01.CIR.102.25.3104
10.1074/jbc.M213093200
10.1161/01.CIR.97.12.1129
10.1182/blood-2002-08-2675
10.1016/j.cardiores.2003.11.032
10.1164/ajrccm.157.5.9709020
10.1074/jbc.M201253200
10.18388/abp.1994_4718
10.1006/bcmd.2000.0376
10.1002/mc.10145
10.1128/MCB.25.5.1608-1619.2005
10.1016/S0021-9258(19)69848-0
10.1016/S0955-0674(03)00098-X
10.1210/en.2003-0098
10.1097/00062752-200207000-00010
10.1517/13543784.13.1.21
10.1016/j.canlet.2003.08.035
10.1006/bbrc.1994.2861
10.1038/sj.onc.1202792
10.1182/blood-2005-06-2409
ContentType Journal Article
Copyright 2007 Elsevier Inc.
Copyright_xml – notice: 2007 Elsevier Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TM
5PM
DOI 10.1016/j.bbrc.2007.11.002
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Nucleic Acids Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Nucleic Acids Abstracts
DatabaseTitleList
MEDLINE

Nucleic Acids Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Biology
EISSN 1090-2104
EndPage 392
ExternalDocumentID 10_1016_j_bbrc_2007_11_002
17996726
S0006291X07023844
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01 HL066053
– fundername: NHLBI NIH HHS
  grantid: R01 HL066053-04
– fundername: NHLBI NIH HHS
  grantid: R01-HL066053
GroupedDBID ---
--K
--M
-~X
.55
.GJ
.HR
.~1
0R~
1B1
1CY
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5VS
6J9
7-5
71M
8P~
9JM
9M8
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
AAYJJ
ABEFU
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACKIV
ACNCT
ACRLP
ADBBV
ADEZE
ADFGL
ADIYS
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CAG
COF
CS3
D0L
DM4
DOVZS
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
G8K
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
LG5
LX2
M41
MO0
MVM
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
RNS
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
TWZ
UQL
WH7
WUQ
X7M
XPP
XSW
Y6R
ZA5
ZGI
ZKB
ZMT
~02
~G-
~KM
AAHBH
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AFJKZ
CITATION
7TM
5PM
ID FETCH-LOGICAL-c484t-ba9c94b59c8fd4656858f36f89ca0c266960b85692e3f1a51e3b3136cb07c8893
IEDL.DBID AIKHN
ISSN 0006-291X
IngestDate Tue Sep 17 21:26:48 EDT 2024
Sun Sep 29 07:39:47 EDT 2024
Thu Sep 26 17:11:54 EDT 2024
Sat Sep 28 07:52:06 EDT 2024
Fri Feb 23 02:27:24 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords HMG-CoA
TSA
Statin
RhoA
Apoptosis
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c484t-ba9c94b59c8fd4656858f36f89ca0c266960b85692e3f1a51e3b3136cb07c8893
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://europepmc.org/articles/pmc2151206?pdf=render
PMID 17996726
PQID 20480720
PQPubID 23462
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2151206
proquest_miscellaneous_20480720
crossref_primary_10_1016_j_bbrc_2007_11_002
pubmed_primary_17996726
elsevier_sciencedirect_doi_10_1016_j_bbrc_2007_11_002
PublicationCentury 2000
PublicationDate 2008-01-11
PublicationDateYYYYMMDD 2008-01-11
PublicationDate_xml – month: 01
  year: 2008
  text: 2008-01-11
  day: 11
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Biochemical and biophysical research communications
PublicationTitleAlternate Biochem Biophys Res Commun
PublicationYear 2008
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Ghosh, Ghosh-Choudhury, Moyer, Mott, Thomas, Foster, Greenberg, Kreisberg (bib5) 1999; 18
Gan, Shen, Utama, Wang, Coselli, Wang (bib26) 2006; 340
Winter-Vann, Casey (bib1) 2005; 5
Li, Liu, Tupper, Bannerman, Winn, Sebti, Hamilton, Harlan (bib7) 2002; 277
Duan, Heckman, Boxer (bib18) 2005; 25
Zhong, Liang, Wang, Chang, Lee (bib33) 2005; 12
Laufs, La Fata, Plutzky, Liao (bib37) 1998; 97
Aznar, Lacal (bib30) 2001; 165
Rubins, Greatens, Kratzke, Tan, Polunovsky, Bitterman (bib6) 1998; 157
Cafforio, Dammacco, Gernone, Silvestris (bib11) 2005; 26
Donadelli, Costanzo, Faggioli, Scupoli, Moore, Bassi, Scarpa, Palmieri (bib17) 2003; 38
Denoyelle, Albanese, Uzan, Hong, Vannier, Soria, Soria (bib9) 2003; 15
Fritz (bib2) 2005; 27
Schmidt, Gust, Jung (bib14) 1999; 332
Sagami, Morita, Korenaga, Ogura (bib3) 1994; 41
Nimmanapalli, Fuino, Stobaugh, Richon, Bhalla (bib21) 2003; 101
Maggio, Rosato, Kramer, Dai, Rahmani, Paik, Czarnik, Payne, Spiegel, Grant (bib22) 2004; 64
Henderson, Mizzau, Paroni, Maestro, Schneider, Brancolini (bib27) 2003; 278
Aznar, Fernandez-Valeron, Espina, Lacal (bib13) 2004; 206
Rosato, Grant (bib36) 2004; 13
Gan, Shen, Wang, Wang, Utama, Wang, Wang (bib28) 2005; 280
Butler, Agus, Scher, Higgins, Rose, Cordon-Cardo, Thaler, Rifkind, Marks, Richon (bib15) 2000; 60
Moomaw, Casey (bib34) 1992; 267
Jones, Couldwell, Hinton, Su, He, Anker, Law (bib4) 1994; 205
Rahmani, Reese, Dai, Bauer, Payne, Dent, Spiegel, Grant (bib23) 2005; 65
Marks, Richon, Breslow, Rifkind (bib19) 2001; 13
Malliri, Collard (bib39) 2003; 15
Hall (bib31) 2005; 33
Porter, Turner, O’Regan, Balmforth, Ball (bib32) 2004; 61
Zhong, Wang, Chang, Lee (bib10) 2003; 144
Rossig, Li, Fisslthaler, Urbich, Fleming, Forstermann, Zeiher, Dimmeler (bib25) 2002; 91
Bordier (bib29) 1981; 256
Ridley (bib40) 2004; 84
Roskoski (bib12) 2003; 303
Melnick, Licht (bib20) 2002; 9
Richon, Zhou, Rifkind, Marks (bib35) 2001; 27
Herold, Ganslmayer, Ocker, Hermann, Geerts, Hahn, Schuppan (bib16) 2002; 36
Laufs, Endres, Custodis, Gertz, Nickenig, Liao, Bohm (bib38) 2000; 102
Blanco-Colio, Villa, Ortego, Hernandez-Presa, Pascual, Plaza, Egido (bib8) 2002; 161
Gao, Rahmani, Shi, Dent, Grant (bib24) 2006; 107
11248412 - Cancer Lett. 2001 Apr 10;165(1):1-10
9603146 - Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1616-22
11120702 - Circulation. 2000 Dec 19;102(25):3104-10
12556448 - J Biol Chem. 2003 Apr 4;278(14):12579-89
15059916 - Cancer Res. 2004 Apr 1;64(7):2590-600
7811252 - Biochem Biophys Res Commun. 1994 Dec 30;205(3):1681-7
15864282 - Nat Rev Cancer. 2005 May;5(5):405-12
12042707 - Curr Opin Hematol. 2002 Jul;9(4):322-32
14999150 - Breast Cancer Res Treat. 2004 Mar;84(1):13-9
11882313 - Atherosclerosis. 2002 Mar;161(1):17-26
1512274 - J Biol Chem. 1992 Aug 25;267(24):17438-43
11830335 - J Hepatol. 2002 Feb;36(2):233-40
16172195 - Endocr Relat Cancer. 2005 Sep;12(3):615-29
10575368 - Arch Pharm (Weinheim). 1999 Oct;332(10):353-7
11358386 - Blood Cells Mol Dis. 2001 Jan-Feb;27(1):260-4
12446442 - Blood. 2003 Apr 15;101(8):3236-9
11016644 - Cancer Res. 2000 Sep 15;60(18):5165-70
15013523 - Cancer Lett. 2004 Apr 8;206(2):181-91
16338217 - Biochem Biophys Res Commun. 2006 Feb 3;340(1):29-34
16246005 - Biochem Soc Trans. 2005 Nov;33(Pt 5):891-5
12646157 - Biochem Biophys Res Commun. 2003 Mar 28;303(1):1-7
9537338 - Circulation. 1998 Mar 31;97(12):1129-35
14502645 - Mol Carcinog. 2003 Oct;38(2):59-69
6257680 - J Biol Chem. 1981 Feb 25;256(4):1604-7
12933658 - Endocrinology. 2003 Sep;144(9):3852-9
15713621 - Mol Cell Biol. 2005 Mar;25(5):1608-19
10435593 - Oncogene. 1999 Jul 15;18(28):4120-30
11673688 - Curr Opin Oncol. 2001 Nov;13(6):477-83
12411399 - Circ Res. 2002 Nov 1;91(9):837-44
15705602 - Carcinogenesis. 2005 May;26(5):883-91
14680450 - Expert Opin Investig Drugs. 2004 Jan;13(1):21-38
14985071 - Cardiovasc Res. 2004 Mar 1;61(4):745-55
15781658 - Cancer Res. 2005 Mar 15;65(6):2422-32
16211237 - Int J Oncol. 2005 Nov;27(5):1401-9
12531431 - Cell Signal. 2003 Mar;15(3):327-38
16141349 - Blood. 2006 Jan 1;107(1):241-9
11839765 - J Biol Chem. 2002 May 3;277(18):15309-16
15722551 - J Biol Chem. 2005 Apr 22;280(16):16467-75
14519393 - Curr Opin Cell Biol. 2003 Oct;15(5):583-9
7856400 - Acta Biochim Pol. 1994;41(3):293-302
Gao (10.1016/j.bbrc.2007.11.002_bib24) 2006; 107
Aznar (10.1016/j.bbrc.2007.11.002_bib13) 2004; 206
Herold (10.1016/j.bbrc.2007.11.002_bib16) 2002; 36
Maggio (10.1016/j.bbrc.2007.11.002_bib22) 2004; 64
Ghosh (10.1016/j.bbrc.2007.11.002_bib5) 1999; 18
Malliri (10.1016/j.bbrc.2007.11.002_bib39) 2003; 15
Fritz (10.1016/j.bbrc.2007.11.002_bib2) 2005; 27
Porter (10.1016/j.bbrc.2007.11.002_bib32) 2004; 61
Rosato (10.1016/j.bbrc.2007.11.002_bib36) 2004; 13
Winter-Vann (10.1016/j.bbrc.2007.11.002_bib1) 2005; 5
Schmidt (10.1016/j.bbrc.2007.11.002_bib14) 1999; 332
Richon (10.1016/j.bbrc.2007.11.002_bib35) 2001; 27
Blanco-Colio (10.1016/j.bbrc.2007.11.002_bib8) 2002; 161
Rahmani (10.1016/j.bbrc.2007.11.002_bib23) 2005; 65
Denoyelle (10.1016/j.bbrc.2007.11.002_bib9) 2003; 15
Rubins (10.1016/j.bbrc.2007.11.002_bib6) 1998; 157
Gan (10.1016/j.bbrc.2007.11.002_bib28) 2005; 280
Donadelli (10.1016/j.bbrc.2007.11.002_bib17) 2003; 38
Gan (10.1016/j.bbrc.2007.11.002_bib26) 2006; 340
Laufs (10.1016/j.bbrc.2007.11.002_bib37) 1998; 97
Marks (10.1016/j.bbrc.2007.11.002_bib19) 2001; 13
Duan (10.1016/j.bbrc.2007.11.002_bib18) 2005; 25
Bordier (10.1016/j.bbrc.2007.11.002_bib29) 1981; 256
Rossig (10.1016/j.bbrc.2007.11.002_bib25) 2002; 91
Ridley (10.1016/j.bbrc.2007.11.002_bib40) 2004; 84
Sagami (10.1016/j.bbrc.2007.11.002_bib3) 1994; 41
Roskoski (10.1016/j.bbrc.2007.11.002_bib12) 2003; 303
Aznar (10.1016/j.bbrc.2007.11.002_bib30) 2001; 165
Nimmanapalli (10.1016/j.bbrc.2007.11.002_bib21) 2003; 101
Hall (10.1016/j.bbrc.2007.11.002_bib31) 2005; 33
Melnick (10.1016/j.bbrc.2007.11.002_bib20) 2002; 9
Zhong (10.1016/j.bbrc.2007.11.002_bib10) 2003; 144
Moomaw (10.1016/j.bbrc.2007.11.002_bib34) 1992; 267
Laufs (10.1016/j.bbrc.2007.11.002_bib38) 2000; 102
Jones (10.1016/j.bbrc.2007.11.002_bib4) 1994; 205
Henderson (10.1016/j.bbrc.2007.11.002_bib27) 2003; 278
Zhong (10.1016/j.bbrc.2007.11.002_bib33) 2005; 12
Cafforio (10.1016/j.bbrc.2007.11.002_bib11) 2005; 26
Butler (10.1016/j.bbrc.2007.11.002_bib15) 2000; 60
Li (10.1016/j.bbrc.2007.11.002_bib7) 2002; 277
References_xml – volume: 107
  start-page: 241
  year: 2006
  end-page: 249
  ident: bib24
  article-title: Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stress
  publication-title: Blood
  contributor:
    fullname: Grant
– volume: 340
  start-page: 29
  year: 2006
  end-page: 34
  ident: bib26
  article-title: Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Wang
– volume: 277
  start-page: 15309
  year: 2002
  end-page: 15316
  ident: bib7
  article-title: Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Harlan
– volume: 97
  start-page: 1129
  year: 1998
  end-page: 1135
  ident: bib37
  article-title: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
  publication-title: Circulation
  contributor:
    fullname: Liao
– volume: 13
  start-page: 21
  year: 2004
  end-page: 38
  ident: bib36
  article-title: Histone deacetylase inhibitors in clinical development
  publication-title: Expert Opin. Investig. Drugs
  contributor:
    fullname: Grant
– volume: 205
  start-page: 1681
  year: 1994
  end-page: 1687
  ident: bib4
  article-title: Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Law
– volume: 12
  start-page: 615
  year: 2005
  end-page: 629
  ident: bib33
  article-title: Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling
  publication-title: Endocr. Relat. Cancer
  contributor:
    fullname: Lee
– volume: 102
  start-page: 3104
  year: 2000
  end-page: 3110
  ident: bib38
  article-title: Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription
  publication-title: Circulation
  contributor:
    fullname: Bohm
– volume: 9
  start-page: 322
  year: 2002
  end-page: 332
  ident: bib20
  article-title: Histone deacetylases as therapeutic targets in hematologic malignancies
  publication-title: Curr. Opin. Hematol.
  contributor:
    fullname: Licht
– volume: 13
  start-page: 477
  year: 2001
  end-page: 483
  ident: bib19
  article-title: Histone deacetylase inhibitors as new cancer drugs
  publication-title: Curr. Opin. Oncol.
  contributor:
    fullname: Rifkind
– volume: 84
  start-page: 13
  year: 2004
  end-page: 19
  ident: bib40
  article-title: Rho proteins and cancer
  publication-title: Breast Cancer Res. Treat.
  contributor:
    fullname: Ridley
– volume: 41
  start-page: 293
  year: 1994
  end-page: 302
  ident: bib3
  article-title: Purification of geranylgeranyl diphosphate synthase from bovine brain
  publication-title: Acta Biochim. Pol.
  contributor:
    fullname: Ogura
– volume: 256
  start-page: 1604
  year: 1981
  end-page: 1607
  ident: bib29
  article-title: Phase separation of integral membrane proteins in Triton X-114 solution
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Bordier
– volume: 27
  start-page: 260
  year: 2001
  end-page: 264
  ident: bib35
  article-title: Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers
  publication-title: Blood Cells Mol. Dis.
  contributor:
    fullname: Marks
– volume: 25
  start-page: 1608
  year: 2005
  end-page: 1619
  ident: bib18
  article-title: Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Boxer
– volume: 267
  start-page: 17438
  year: 1992
  end-page: 17443
  ident: bib34
  article-title: Mammalian protein geranylgeranyltransferase. Subunit composition and metal requirements
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Casey
– volume: 64
  start-page: 2590
  year: 2004
  end-page: 2600
  ident: bib22
  article-title: The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells
  publication-title: Cancer Res.
  contributor:
    fullname: Grant
– volume: 5
  start-page: 405
  year: 2005
  end-page: 412
  ident: bib1
  article-title: Post-prenylation-processing enzymes as new targets in oncogenesis
  publication-title: Nat. Rev. Cancer
  contributor:
    fullname: Casey
– volume: 157
  start-page: 1616
  year: 1998
  end-page: 1622
  ident: bib6
  article-title: Lovastatin induces apoptosis in malignant mesothelioma cells
  publication-title: Am. J. Respir. Crit. Care Med.
  contributor:
    fullname: Bitterman
– volume: 60
  start-page: 5165
  year: 2000
  end-page: 5170
  ident: bib15
  article-title: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
  publication-title: Cancer Res.
  contributor:
    fullname: Richon
– volume: 165
  start-page: 1
  year: 2001
  end-page: 10
  ident: bib30
  article-title: Rho signals to cell growth and apoptosis
  publication-title: Cancer Lett.
  contributor:
    fullname: Lacal
– volume: 38
  start-page: 59
  year: 2003
  end-page: 69
  ident: bib17
  article-title: Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells
  publication-title: Mol. Carcinog.
  contributor:
    fullname: Palmieri
– volume: 161
  start-page: 17
  year: 2002
  end-page: 26
  ident: bib8
  article-title: 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation
  publication-title: Atherosclerosis
  contributor:
    fullname: Egido
– volume: 15
  start-page: 327
  year: 2003
  end-page: 338
  ident: bib9
  article-title: Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells
  publication-title: Cell Signal
  contributor:
    fullname: Soria
– volume: 36
  start-page: 233
  year: 2002
  end-page: 240
  ident: bib16
  article-title: The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells
  publication-title: J. Hepatol.
  contributor:
    fullname: Schuppan
– volume: 144
  start-page: 3852
  year: 2003
  end-page: 3859
  ident: bib10
  article-title: Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis
  publication-title: Endocrinology
  contributor:
    fullname: Lee
– volume: 26
  start-page: 883
  year: 2005
  end-page: 891
  ident: bib11
  article-title: Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells
  publication-title: Carcinogenesis
  contributor:
    fullname: Silvestris
– volume: 15
  start-page: 583
  year: 2003
  end-page: 589
  ident: bib39
  article-title: Role of Rho-family proteins in cell adhesion and cancer
  publication-title: Curr. Opin. Cell Biol.
  contributor:
    fullname: Collard
– volume: 332
  start-page: 353
  year: 1999
  end-page: 357
  ident: bib14
  article-title: Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells
  publication-title: Arch. Pharm. (Weinheim)
  contributor:
    fullname: Jung
– volume: 303
  start-page: 1
  year: 2003
  end-page: 7
  ident: bib12
  article-title: Protein prenylation: a pivotal posttranslational process
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Roskoski
– volume: 278
  start-page: 12579
  year: 2003
  end-page: 12589
  ident: bib27
  article-title: Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA)
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Brancolini
– volume: 27
  start-page: 1401
  year: 2005
  end-page: 1409
  ident: bib2
  article-title: HMG-CoA reductase inhibitors (statins) as anticancer drugs (review)
  publication-title: Int. J. Oncol.
  contributor:
    fullname: Fritz
– volume: 33
  start-page: 891
  year: 2005
  end-page: 895
  ident: bib31
  article-title: Rho GTPases and the control of cell behaviour
  publication-title: Biochem. Soc. Trans.
  contributor:
    fullname: Hall
– volume: 280
  start-page: 16467
  year: 2005
  end-page: 16475
  ident: bib28
  article-title: Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Wang
– volume: 18
  start-page: 4120
  year: 1999
  end-page: 4130
  ident: bib5
  article-title: Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line
  publication-title: Oncogene
  contributor:
    fullname: Kreisberg
– volume: 101
  start-page: 3236
  year: 2003
  end-page: 3239
  ident: bib21
  article-title: Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells
  publication-title: Blood
  contributor:
    fullname: Bhalla
– volume: 65
  start-page: 2422
  year: 2005
  end-page: 2432
  ident: bib23
  article-title: Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species
  publication-title: Cancer Res.
  contributor:
    fullname: Grant
– volume: 91
  start-page: 837
  year: 2002
  end-page: 844
  ident: bib25
  article-title: Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis
  publication-title: Circ. Res.
  contributor:
    fullname: Dimmeler
– volume: 61
  start-page: 745
  year: 2004
  end-page: 755
  ident: bib32
  article-title: Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA
  publication-title: Cardiovasc. Res.
  contributor:
    fullname: Ball
– volume: 206
  start-page: 181
  year: 2004
  end-page: 191
  ident: bib13
  article-title: Rho GTPases: potential candidates for anticancer therapy
  publication-title: Cancer Lett.
  contributor:
    fullname: Lacal
– volume: 165
  start-page: 1
  year: 2001
  ident: 10.1016/j.bbrc.2007.11.002_bib30
  article-title: Rho signals to cell growth and apoptosis
  publication-title: Cancer Lett.
  doi: 10.1016/S0304-3835(01)00412-8
  contributor:
    fullname: Aznar
– volume: 161
  start-page: 17
  year: 2002
  ident: 10.1016/j.bbrc.2007.11.002_bib8
  article-title: 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(01)00613-X
  contributor:
    fullname: Blanco-Colio
– volume: 84
  start-page: 13
  year: 2004
  ident: 10.1016/j.bbrc.2007.11.002_bib40
  article-title: Rho proteins and cancer
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1023/B:BREA.0000018423.47497.c6
  contributor:
    fullname: Ridley
– volume: 5
  start-page: 405
  year: 2005
  ident: 10.1016/j.bbrc.2007.11.002_bib1
  article-title: Post-prenylation-processing enzymes as new targets in oncogenesis
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1612
  contributor:
    fullname: Winter-Vann
– volume: 26
  start-page: 883
  year: 2005
  ident: 10.1016/j.bbrc.2007.11.002_bib11
  article-title: Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgi036
  contributor:
    fullname: Cafforio
– volume: 36
  start-page: 233
  year: 2002
  ident: 10.1016/j.bbrc.2007.11.002_bib16
  article-title: The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells
  publication-title: J. Hepatol.
  doi: 10.1016/S0168-8278(01)00257-4
  contributor:
    fullname: Herold
– volume: 15
  start-page: 327
  year: 2003
  ident: 10.1016/j.bbrc.2007.11.002_bib9
  article-title: Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells
  publication-title: Cell Signal
  doi: 10.1016/S0898-6568(02)00124-9
  contributor:
    fullname: Denoyelle
– volume: 332
  start-page: 353
  year: 1999
  ident: 10.1016/j.bbrc.2007.11.002_bib14
  article-title: Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells
  publication-title: Arch. Pharm. (Weinheim)
  doi: 10.1002/(SICI)1521-4184(199910)332:10<353::AID-ARDP353>3.0.CO;2-X
  contributor:
    fullname: Schmidt
– volume: 340
  start-page: 29
  year: 2006
  ident: 10.1016/j.bbrc.2007.11.002_bib26
  article-title: Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2005.11.151
  contributor:
    fullname: Gan
– volume: 13
  start-page: 477
  year: 2001
  ident: 10.1016/j.bbrc.2007.11.002_bib19
  article-title: Histone deacetylase inhibitors as new cancer drugs
  publication-title: Curr. Opin. Oncol.
  doi: 10.1097/00001622-200111000-00010
  contributor:
    fullname: Marks
– volume: 65
  start-page: 2422
  year: 2005
  ident: 10.1016/j.bbrc.2007.11.002_bib23
  article-title: Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-04-2440
  contributor:
    fullname: Rahmani
– volume: 64
  start-page: 2590
  year: 2004
  ident: 10.1016/j.bbrc.2007.11.002_bib22
  article-title: The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-03-2631
  contributor:
    fullname: Maggio
– volume: 27
  start-page: 1401
  year: 2005
  ident: 10.1016/j.bbrc.2007.11.002_bib2
  article-title: HMG-CoA reductase inhibitors (statins) as anticancer drugs (review)
  publication-title: Int. J. Oncol.
  contributor:
    fullname: Fritz
– volume: 33
  start-page: 891
  year: 2005
  ident: 10.1016/j.bbrc.2007.11.002_bib31
  article-title: Rho GTPases and the control of cell behaviour
  publication-title: Biochem. Soc. Trans.
  doi: 10.1042/BST0330891
  contributor:
    fullname: Hall
– volume: 280
  start-page: 16467
  year: 2005
  ident: 10.1016/j.bbrc.2007.11.002_bib28
  article-title: Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M412960200
  contributor:
    fullname: Gan
– volume: 60
  start-page: 5165
  year: 2000
  ident: 10.1016/j.bbrc.2007.11.002_bib15
  article-title: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
  publication-title: Cancer Res.
  contributor:
    fullname: Butler
– volume: 12
  start-page: 615
  year: 2005
  ident: 10.1016/j.bbrc.2007.11.002_bib33
  article-title: Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling
  publication-title: Endocr. Relat. Cancer
  doi: 10.1677/erc.1.01012
  contributor:
    fullname: Zhong
– volume: 91
  start-page: 837
  year: 2002
  ident: 10.1016/j.bbrc.2007.11.002_bib25
  article-title: Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis
  publication-title: Circ. Res.
  doi: 10.1161/01.RES.0000037983.07158.B1
  contributor:
    fullname: Rossig
– volume: 303
  start-page: 1
  year: 2003
  ident: 10.1016/j.bbrc.2007.11.002_bib12
  article-title: Protein prenylation: a pivotal posttranslational process
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/S0006-291X(03)00323-1
  contributor:
    fullname: Roskoski
– volume: 267
  start-page: 17438
  year: 1992
  ident: 10.1016/j.bbrc.2007.11.002_bib34
  article-title: Mammalian protein geranylgeranyltransferase. Subunit composition and metal requirements
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)41945-X
  contributor:
    fullname: Moomaw
– volume: 102
  start-page: 3104
  year: 2000
  ident: 10.1016/j.bbrc.2007.11.002_bib38
  article-title: Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription
  publication-title: Circulation
  doi: 10.1161/01.CIR.102.25.3104
  contributor:
    fullname: Laufs
– volume: 278
  start-page: 12579
  year: 2003
  ident: 10.1016/j.bbrc.2007.11.002_bib27
  article-title: Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA)
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M213093200
  contributor:
    fullname: Henderson
– volume: 97
  start-page: 1129
  year: 1998
  ident: 10.1016/j.bbrc.2007.11.002_bib37
  article-title: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
  publication-title: Circulation
  doi: 10.1161/01.CIR.97.12.1129
  contributor:
    fullname: Laufs
– volume: 101
  start-page: 3236
  year: 2003
  ident: 10.1016/j.bbrc.2007.11.002_bib21
  article-title: Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells
  publication-title: Blood
  doi: 10.1182/blood-2002-08-2675
  contributor:
    fullname: Nimmanapalli
– volume: 61
  start-page: 745
  year: 2004
  ident: 10.1016/j.bbrc.2007.11.002_bib32
  article-title: Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA
  publication-title: Cardiovasc. Res.
  doi: 10.1016/j.cardiores.2003.11.032
  contributor:
    fullname: Porter
– volume: 157
  start-page: 1616
  year: 1998
  ident: 10.1016/j.bbrc.2007.11.002_bib6
  article-title: Lovastatin induces apoptosis in malignant mesothelioma cells
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/ajrccm.157.5.9709020
  contributor:
    fullname: Rubins
– volume: 277
  start-page: 15309
  year: 2002
  ident: 10.1016/j.bbrc.2007.11.002_bib7
  article-title: Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M201253200
  contributor:
    fullname: Li
– volume: 41
  start-page: 293
  year: 1994
  ident: 10.1016/j.bbrc.2007.11.002_bib3
  article-title: Purification of geranylgeranyl diphosphate synthase from bovine brain
  publication-title: Acta Biochim. Pol.
  doi: 10.18388/abp.1994_4718
  contributor:
    fullname: Sagami
– volume: 27
  start-page: 260
  year: 2001
  ident: 10.1016/j.bbrc.2007.11.002_bib35
  article-title: Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers
  publication-title: Blood Cells Mol. Dis.
  doi: 10.1006/bcmd.2000.0376
  contributor:
    fullname: Richon
– volume: 38
  start-page: 59
  year: 2003
  ident: 10.1016/j.bbrc.2007.11.002_bib17
  article-title: Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells
  publication-title: Mol. Carcinog.
  doi: 10.1002/mc.10145
  contributor:
    fullname: Donadelli
– volume: 25
  start-page: 1608
  year: 2005
  ident: 10.1016/j.bbrc.2007.11.002_bib18
  article-title: Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.25.5.1608-1619.2005
  contributor:
    fullname: Duan
– volume: 256
  start-page: 1604
  year: 1981
  ident: 10.1016/j.bbrc.2007.11.002_bib29
  article-title: Phase separation of integral membrane proteins in Triton X-114 solution
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)69848-0
  contributor:
    fullname: Bordier
– volume: 15
  start-page: 583
  year: 2003
  ident: 10.1016/j.bbrc.2007.11.002_bib39
  article-title: Role of Rho-family proteins in cell adhesion and cancer
  publication-title: Curr. Opin. Cell Biol.
  doi: 10.1016/S0955-0674(03)00098-X
  contributor:
    fullname: Malliri
– volume: 144
  start-page: 3852
  year: 2003
  ident: 10.1016/j.bbrc.2007.11.002_bib10
  article-title: Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis
  publication-title: Endocrinology
  doi: 10.1210/en.2003-0098
  contributor:
    fullname: Zhong
– volume: 9
  start-page: 322
  year: 2002
  ident: 10.1016/j.bbrc.2007.11.002_bib20
  article-title: Histone deacetylases as therapeutic targets in hematologic malignancies
  publication-title: Curr. Opin. Hematol.
  doi: 10.1097/00062752-200207000-00010
  contributor:
    fullname: Melnick
– volume: 13
  start-page: 21
  year: 2004
  ident: 10.1016/j.bbrc.2007.11.002_bib36
  article-title: Histone deacetylase inhibitors in clinical development
  publication-title: Expert Opin. Investig. Drugs
  doi: 10.1517/13543784.13.1.21
  contributor:
    fullname: Rosato
– volume: 206
  start-page: 181
  year: 2004
  ident: 10.1016/j.bbrc.2007.11.002_bib13
  article-title: Rho GTPases: potential candidates for anticancer therapy
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2003.08.035
  contributor:
    fullname: Aznar
– volume: 205
  start-page: 1681
  year: 1994
  ident: 10.1016/j.bbrc.2007.11.002_bib4
  article-title: Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.1994.2861
  contributor:
    fullname: Jones
– volume: 18
  start-page: 4120
  year: 1999
  ident: 10.1016/j.bbrc.2007.11.002_bib5
  article-title: Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1202792
  contributor:
    fullname: Ghosh
– volume: 107
  start-page: 241
  year: 2006
  ident: 10.1016/j.bbrc.2007.11.002_bib24
  article-title: Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stress
  publication-title: Blood
  doi: 10.1182/blood-2005-06-2409
  contributor:
    fullname: Gao
SSID ssj0011469
Score 2.0165298
Snippet HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 386
SubjectTerms Acyl Coenzyme A - metabolism
Apoptosis
Apoptosis - drug effects
Dose-Response Relationship, Drug
HeLa Cells
Histone Deacetylase Inhibitors
Histone Deacetylases - metabolism
HMG-CoA
Humans
Hydroxamic Acids - administration & dosage
Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage
Lovastatin - administration & dosage
Lovastatin - analogs & derivatives
RhoA
Statin
TSA
Title Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells
URI https://dx.doi.org/10.1016/j.bbrc.2007.11.002
https://www.ncbi.nlm.nih.gov/pubmed/17996726
https://search.proquest.com/docview/20480720
https://pubmed.ncbi.nlm.nih.gov/PMC2151206
Volume 365
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61WyG4IGiBLtDiA-KCTPOyYx-XFSU82gtU2ltkO44apCarJD3shd_OOHFKFyoO3KLElib-rHl4Zj4DvC4DExUY-1ApSk2TggdUJoHLwZcJN7hJSusanM_OeXaRfF6x1Q4sp14YV1bpdf-o0wdt7d-c-NU8WVeV6_ENeCTDFW5atDtJsgt7Q5JoBnuLT1-y85tkAioD7wVz6ib43pmxzEvr1jMZOjJPf7pyh3362__8s4zyll06fQQPvUNJFqPMj2HH1vtwsKgxmL7akDdkKPEczs734d776en-crro7QDabxvXADgwNhMM0Uc-WdKURK2bdd90VUf0hmRnH-myWZDWkb32aPxw7GWlUSO0RNUFGZiLa0sKVLK236BXbrtbQ6qaZParIi5T0D2Bi9MP35cZ9VcxUJOIpKdaSSMTzaQRZeEo1gQTZcxLIY1CtDnHQEgLxmVk4zJULLSxjsOYGx2kRqBP9BRmNcpwCMQwJW3MCsdViMAwoY01kURHTCkti2AObycA8vXIuJFPpWg_cgeXuzozxdAlR7jmwCaM8q19k6NJ-Oe8VxOgOS63-3dV2-a6y6Ohyz5COZ6N8P6WIsXgMI34HNIt4G8GOKru7S91dTlQdg-OVcCf_6e0L-DBWKcS0jB8CbO-vbZH6Az1-hh23_0Mj_2W_wW13gpa
link.rule.ids 230,315,783,787,888,4511,24130,27938,27939,45599,45693
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKESoXBC2U5VUfEBdkmoft2MdlRQmw2wuttLfIdhw1SCSrJD3shd_O2HFKFxAHblEykSb-RvOIZz4j9LqKTFJC7UOkqDShJY-IpJHbg68oN2AklXUDzqtznl_Sz2u23kOLaRbGtVUG3z_6dO-tw53TsJqnm7p2M74RT2S8BqOFuEPpHXSXOv4sMOp3P276PNzUbciBOXHiYXJmbPLSugs8ho7KM_xb-Ut0-jP7_L2J8lZUOnuIHoR0Es9HjR-hPdscoqN5A6X09y1-g32Dp_9zfojuvZ-uDhbTMW9HqPu6deN_nq8ZQ4E-ssnitsJq026Gtq97rLc4X30ki3aOO0f1OkDoA9mrWoM_6LBqSux5ixuLS3CxdthCTm77WyJ1g3O7VNjtE_SP0eXZh4tFTsJBDMRQQQeilTSSaiaNqEpHsCaYqFJeCWkUYM05lEFaMC4Tm1axYrFNdRqn3OgoMwIyoidovwEdniJsmJI2ZaVjKgRgmNDGmkRCGqaUlmU0Q28nAIrNyLdRTI1o3woHlzs4M4PCpQC4ZohNGBU7VlNAQPjneycToAUst_t21dj2ui8SP2OfgB7HI7y_tMigNMwSPkPZDvA3Ao6oe_dJU195wm6fVkX82X9qe4IO8ovVslh-Ov_yHN0fO1ZiEscv0P7QXduXkBYN-pU3-59A-Qs8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synergistic+induction+of+apoptosis+by+HMG-CoA+reductase+inhibitor+and+histone+deacetylases+inhibitor+in+HeLa+cells&rft.jtitle=Biochemical+and+biophysical+research+communications&rft.au=Gan%2C+Yehua&rft.au=Wang%2C+Jian&rft.au=Coselli%2C+Joseph&rft.au=Wang%2C+Xing+Li&rft.date=2008-01-11&rft.pub=Elsevier+Inc&rft.issn=0006-291X&rft.eissn=1090-2104&rft.volume=365&rft.issue=2&rft.spage=386&rft.epage=392&rft_id=info:doi/10.1016%2Fj.bbrc.2007.11.002&rft.externalDocID=S0006291X07023844
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-291X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-291X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-291X&client=summon